USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response. Prokakis E, Dyas A, Grun R, Fritzsche S, et al. Oncogene 2021;40:4004-4018.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Prokakis E, Dyas A, Grun R, Fritzsche S, et al. USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response. Oncogene 2021;40:4004-4018.
PMID: 34007022